Role of Transcription Factor Nrf2 in the Induction of Hepatic Phase 2 and Antioxidative Enzymes in vivo by the Cancer Chemoprotective Agent, 3H-1, 2-Dithiole-3-thione
Top Cited Papers
Open Access
- 1 February 2001
- journal article
- research article
- Published by Springer Nature in Molecular Medicine
- Vol. 7 (2) , 135-145
- https://doi.org/10.1007/bf03401947
Abstract
No abstract availableKeywords
This publication has 57 references indexed in Scilit:
- REGULATION OF GENE EXPRESSION BY REACTIVE OXYGENAnnual Review of Pharmacology and Toxicology, 1999
- Redox Modulation of AP-2 DNA Binding Activityin VitroBiochemical and Biophysical Research Communications, 1998
- Isolation of cDNAs representing dithiolethione-responsive genesCarcinogenesis: Integrative Cancer Research, 1996
- Induction of Phase I and Phase II Drug-Metabolizing Enzyme mRNA, Protein, and Activity by BHA, Ethoxyquin, and OltiprazToxicology and Applied Pharmacology, 1995
- The Rat Quinone Reductase Antioxidant Response ElementJournal of Biological Chemistry, 1995
- Activity and Expression of Murine Small Maf Family Protein MafKJournal of Biological Chemistry, 1995
- ARE- and TRE-mediated Regulation of Gene ExpressionJournal of Biological Chemistry, 1995
- Role of quinone methide in the in vitro toxicity of the skin tumor promoter butylated hydroxytoluene hydroperoxideChemical Research in Toxicology, 1993
- Erythroid transcription factor NF-E2 is a haematopoietic-specific basic–leucine zipper proteinNature, 1993
- Comparative effects of butylated hydroxyanisole on hepatic in vivo DNA binding and in vitro biotransformation of aflatoxin B1 in the rat and mouseToxicology and Applied Pharmacology, 1987